Cargando…
The Origin and Immune Recognition of Tumor-Specific Antigens
SIMPLE SUMMARY: Cancer immunology is a rapidly evolving field. In this context, this review article has three objectives. First, to explain the genomic origin of tumor antigens and to emphasize that many of them are encoded by unconventional RNAs. Second, to discuss the inherent limitations of all s...
Autores principales: | Apavaloaei, Anca, Hardy, Marie-Pierre, Thibault, Pierre, Perreault, Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565792/ https://www.ncbi.nlm.nih.gov/pubmed/32932620 http://dx.doi.org/10.3390/cancers12092607 |
Ejemplares similares
-
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
por: Cuevas, Maria Virginia Ruiz, et al.
Publicado: (2023) -
A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
por: Minati, Robin, et al.
Publicado: (2020) -
The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy
por: Hardy, Marie-Pierre, et al.
Publicado: (2019) -
Immunopeptidomics: Reading the Immune Signal That Defines Self From Nonself
por: Thibault, Pierre, et al.
Publicado: (2022) -
The MHC class I peptide repertoire is molded by the transcriptome
por: Fortier, Marie-Hélène, et al.
Publicado: (2008)